Albuterol

Verify with FDA CVM →

80 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
80
Total Reports
22
Deaths Reported
2750.0%
Death Rate

Active Ingredients

Albuterol

Administration Routes

UnknownRespiratory (Inhalation)OralOther

Species Affected

Cat 40
Dog 31
Human 7
Horse 2

Most Affected Breeds

Domestic Shorthair 24
Unknown 7
Terrier - Yorkshire 6
Domestic Longhair 3
Cat (unknown) 3
Pug 3
American Shorthair 2
Shih Tzu 2
Maltese 2
Dog (unknown) 2

Most Reported Reactions

Death 14
Abnormal radiograph finding 13
Vomiting 10
Weight loss 9
Cough 9
Death by euthanasia 9
Breathing difficulty 8
Not eating 8
Lack of efficacy - NOS 7
Pulmonary oedema 7
Tachypnoea 7
Other abnormal test result NOS 7

Outcome Breakdown

Ongoing
25 (31.6%)
Outcome Unknown
17 (21.5%)
Died
13 (16.5%)
Recovered/Normal
13 (16.5%)
Euthanized
9 (11.4%)
Recovered with Sequela
2 (2.5%)

Data Summary

Metric Value
Total adverse event reports 80
Reports involving death 22
Case-fatality rate (reported events) 2750.0%
Distinct species in reports 4
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Albuterol Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 80 adverse event reports referencing Albuterol, including 22 reports in which the animal died — a 2750.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Albuterol. Reported administration routes include Unknown, Respiratory (Inhalation), Oral, Other. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Albuterol reports are Cat (40 reports), Dog (31 reports), Human (7 reports), with Cat accounting for the largest share. Within those species, Domestic Shorthair (24), Unknown (7), Terrier - Yorkshire (6) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Albuterol are Death (14), Abnormal radiograph finding (13), Vomiting (10), Weight loss (9). Of the 79 reports with a coded outcome, Ongoing is the leading category at 31.6%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Albuterol.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial